Occudo Quantitative Strategies’s Atlanta Braves Holdings Series A BATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,262
Closed -$285K 696
2025
Q3
$285K Buy
6,262
+359
+6% +$17K 0.03% 495
2025
Q2
$290K Buy
5,903
+921
+18% +$40.7K 0.03% 474
2025
Q1
$220K Sell
4,982
-401
-7% -$17.1K 0.03% 540
2024
Q4
$220K Buy
+5,383
New +$226K 0.04% 547
2024
Q2
Sell
-8,144
Closed -$318K 755
2024
Q1
$318K Sell
8,144
-26,112
-76% -$1.1M 0.06% 451
2023
Q4
$1.37M Sell
34,256
-3,937
-10% -$158K 0.19% 153
2023
Q3
$1.39M Buy
38,193
+31,159
+443% +$1.32M 0.18% 169
2023
Q2
$288K Buy
7,034
+711
+11% +$27.5K 0.03% 752
2023
Q1
$219K Sell
6,323
-101
-2% -$3.46K 0.02% 728
2022
Q4
$210K Buy
+6,424
New +$203K 0.02% 762
2022
Q2
Sell
-7,651
Closed -$220K 1137
2022
Q1
$220K Sell
7,651
-2,737
-26% -$73.9K 0.02% 909
2021
Q4
$299K Buy
10,388
+1,822
+21% +$52.6K 0.03% 768
2021
Q3
$231K Buy
+8,566
New +$229K 0.03% 812

Other funds holding BATRA

Occudo Quantitative Strategies's BATRA Position: Q4 2025 in Review

Occudo Quantitative Strategies sold out of Atlanta Braves Holdings Series A (BATRA) in Q4 2025, closing a stake of 6,262 shares — an estimated $285K sold.

Occudo Quantitative Strategies first reported a position in BATRA in Q3 2021 and held it in 13 quarters. The position peaked at $1.39M in Q3 2023. 184 funds tracked by Wall St. Rank hold BATRA as of Q4 2025.

  • Occudo Quantitative Strategies reported no remaining Atlanta Braves Holdings Series A position as of Q4 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 6,262 Atlanta Braves Holdings Series A shares in Q4 2025, an estimated $285K.
  • Occudo Quantitative Strategies first reported a position in Atlanta Braves Holdings Series A in Q3 2021 and held it in 13 quarters.
  • Occudo Quantitative Strategies's Atlanta Braves Holdings Series A position peaked at $1.39M in Q3 2023.
  • 184 funds tracked by Wall St. Rank held Atlanta Braves Holdings Series A as of Q4 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.